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Staphylococcus epidermidis and Staphylococcus aureus are important causative
agents of hospital-acquired infections and bacteremia, likely due to their ability to
form biofilms. The production of a dense exopolysaccharide (EPS) matrix enclosing
the cells slows the penetration of antibiotic down, resulting in therapy failure. The
EPS depolymerase (Dpo7) derived from bacteriophage vB_SepiS-phiIPLA7, was
overexpressed in Escherichia coli and characterized. A dose dependent but time
independent response was observed after treatment of staphylococcal 24 h-biofilms
with Dpo7. Maximum removal (>90%) of biofilm-attached cells was obtained with
0.15 μM of Dpo7 in all polysaccharide producer strains but Dpo7 failed to eliminate
polysaccharide-independent biofilm formed by S. aureus V329. Moreover, the pre-
treatment of polystyrene surfaces with Dpo7 reduced the biofilm biomass by 53–85%
in the 67% of the tested strains. This study supports the use of phage-encoded
EPS depolymerases to prevent and disperse staphylococcal biofilms, thereby making
bacteria more susceptible to the action of antimicrobials.
Keywords: exopolysaccharide depolymerase, biofilm, biofilm matrix, S. epidermidis, S. aureus
INTRODUCTION
Biofilms are surface-attached microbial communities surrounded by a polymeric matrix, which
protects them from the external environment. This complex structure confers to the bacteria a
high resistance to antibiotics, disinfectants and to the host, an immune system response (Hall-
Stoodley and Stoodley, 2009). The ability to develop a biofilm is one of the major virulence factors
in many pathogenic bacteria, while it is a key factor for colonization in opportunistic bacteria.
Staphylococcus epidermidis is a prominent example of a bacterial species with a pathogenicity
associated to the biofilm formation on medical devices (Rupp, 2014), being the most common
cause of bacteremia in immune-compromised patients (Rogers et al., 2009). In addition, methicillin
resistant strains (MRSE) carrying the staphylococcal cassette chromosome mec (SCCmec), are
widely spread within hospitals (Iorio et al., 2012), and provide a reservoir of resistance thatmight be
transferred to Staphylococcus aureus (Otto, 2013), also a frequent cause of nosocomial infections.
S. aureus encodes a number of virulence factors that enable to infect host tissues (Lowy, 1998).
In addition, methicillin-resistant S. aureus (MRSA) isolates, resistant to all available penicillins
and other β-lactam antibiotics, have rapidly disseminated beyond clinical settings among general
population (David and Daum, 2010) and livestock (Price et al., 2012).
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Extracellular material of staphylococcal biofilms is a complex
combination of polysaccharides, teichoic acids, proteins and
DNA. The polysaccharide intercellular adhesin (PIA/PNAG) is a
poly-β-1,6-N-acetyl glucosamine, which production is dependent
on the presence of the operon icaADBC (Mack et al., 1996).
However, staphylococcal strains with a PIA/PNAG-independent
biofilm were also identified. In this case, the extracellular matrix
is based on the presence of adhesive proteins such as Aap,
Embp, Bhp, and Bap (Hussain et al., 1997; Cucarella et al.,
2001; Zhang et al., 2003; Christner et al., 2010). The presence
of teichoic acids in staphylococcal species enhances adhesion
of bacterial cells to fibronectin, increasing their pathogenicity
(Hussain et al., 2001; Vergara-Irigaray et al., 2008). In addition,
a number of microbial surface components recognizing adhesive
matrixmolecules (MSCRAMMs) are able to interact with the host
matrix proteins (Patti et al., 1994). Finally, the modulation of the
extracellular genomic DNA (eDNA) release and degradation was
shown as an important factor in biofilm maturation (Mann et al.,
2009).
Due to the importance of biofilms in hospital settings, several
approaches to prevent and remove them have been assayed. New
materials were designed by coating their surface with different
antimicrobials, like bacteriocins and essential oils, which caused a
reduction in biomass and viability of bacteria in biofilms (Nostro
et al., 2010, 2013). Other changes in physicochemical properties
of biomaterial surfaces resulted in reduction of bacterial adhesion
and further biofilm formation (Tang et al., 2009). Additional
strategies were focused on small molecules that interfere with
the expression of virulence genes including those necessary for
biofilm formation (Ma et al., 2012). Finally, it is noteworthy that
previously formed biofilms can be removed by degrading the
extracellular matrix or by killing the bacteria inside the structure.
Alternatives to antibiotics for killing bacteria and biofilm removal
include bacteriocins (Saising et al., 2012), bacteriophages (Cerca
et al., 2007; Gutiérrez et al., 2012, 2015) and endolysins
(Domenech et al., 2011; Shen et al., 2013; Gutiérrez et al.,
2014). However, to eradicate the biofilm structure a successful
degradation of extracellular matrix is required. Regarding this,
PIA-degrading enzymes like dispersin B (Kaplan et al., 2004) and
bacteriophage-encoded polysaccharide depolymerase proteins
(Cornelissen et al., 2012) have been proposed.
We have previously identified and characterized two
bacteriophages infecting S. epidermidis, vB_SepiS-phiIPLA5 and
vB_SepiS-phiIPLA7, which exhibit plaques surrounded by an
increasing halo zone indicative of the presence of polysaccharide
depolymerase activity (Gutiérrez et al., 2010). Genomic
characterization of phage vB_SepiS-phiIPLA7 showed a protein
(gp18, 98.5 kDa) located in the structural region containing two
catalytic domains. A putative pectin lyase domain was identified
at the amino-terminal part of the protein, and a putative
peptidase domain at the C-terminus. It was suggested that the
anti-biofilm activity showed by phage vB_SepiS-phiIPLA7 may
be attributed to this protein (Gutiérrez et al., 2012). In the present
work, protein gp18 named Dpo7, was overexpressed in E. coli
and purified. The polysaccharide depolymerase activity of Dpo7
was confirmed against S. epidermidis and S. aureus biofilms.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Ten different S. epidermidis strains and two S. aureus strains
were used in this study (Table 1). All bacteria were isolated
in Baird–Parker (BP) agar and routinely cultured in TSB broth
(Tryptic Soy Broth, Scharlau, Barcelona, Spain) at 37◦C with
shaking or in TSB plates containing 2% (w/v) bacteriological agar
(TSA). E. coli transformants were selected on LB medium (1%
tryptone, 0.5% yeast extract, 1% NaCl) supplemented with 2%
(w/v) bacteriological agar and 100 μg ml−1 ampicillin at 37◦C.
Cloning and Overexpression of Dpo7
The codon usage of the orf18 gene, encoding Dpo7 (GenBank
accession number YP_006561180.1) from phage vB_SepiS-
phiIPLA7 was optimized based on E. coli codon usage by
the OptimumGeneTM Codon Optimization Technology.
Additionally, NdeI and XhoI restriction sites were added at
the 5′ and 3′ ends of the sequence, respectively. The optimized
sequence was synthesized and cloned into pUC57 vector by
GenScript (Township, NJ, USA). Afterward, a NdeI-XhoI
fragment containing the orf18 gene was released from pUC57
and sub-cloned into pET21a(+) vector (EMD Biosciences,
San Diego, CA, USA), which introduces a C-terminal 6
His-tag. The construct (pET21a-dpo7) was verified by DNA
sequencing using vector-specific primers (T7 promoter:
5′-TAATACGACTCACTATAGGG-3′ and T7 terminator 5′-
GCTAGTTATTGCTCAGCGG-3′, Eurogentec, Madrid, Spain)
and two internal primers (5′-TCAGAAAGATTCCACGAAGG-
3′ and 5′-TAATGGCCATGTGAGCATC-3′, Eurogentec, Madrid,
Spain).
The plasmid pET21a-dpo7 was electroporated in E. coli
BL21 (DE3) pLysS (Invitrogen Corporation, Gent, Belgium)
and protein expression was carried out as described previously
(Obeso et al., 2008) with 1 mM of IPTG for 16 h at 16◦C. Five
hundred milliliter culture cells were pelleted, suspended in 10 ml
lysis buffer (20 mM NaH2PO4, 500 mMNaCl, 10 mM imidazole,
pH 7.4) and frozen/thawed three times at−80◦C. Sonication was
TABLE 1 | Strains used in this study.
Strain Reference
S. epidermidis F12 Delgado et al., 2009
B
DH3LIK
YLIC13
Z2LDC14
DG2n
ASLD1
LO5081
LV5RB3
LO5RB1
S. aureus 15981 Valle et al., 2003
V329 Cucarella et al., 2001
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carried out afterward 15× 5 s pulses with 15 s recovery on ice and
centrifuged at 10,000× g. The supernatant containing the protein
was purified using the His GraviTrap column kit (GE Healthcare
Life Sciences, Buckinghamshire, UK) following the supplier’s
recommendations. Wash buffer and lysis buffer were composed
of 20mMNaH2PO4, 500mMof NaCl, pH 7.4 with 50 or 500 mM
imidazole, respectively. Protein purity was estimated by SDS-
PAGE and the predicted amino acid sequence was confirmed by
mass spectrometry (MALDI-TOF/TOF) as previously described
(García et al., 2004). Protein amount was quantified by the Quick
Start Bradford Protein Assay (BioRad, Hercules, CA, USA). Prior
to the activity assays, the purified Dpo7 was dialyzed for 16 h
against PBS buffer (137 mMNaCl 2.7 mMKCl 10 mMNa2HPO4
2 mM KH2PO4; pH 7.4).
Biofilm Assays
Biofilms of staphylococcal strains were grown into a TC
Microwell 96U w/lid nunclon D SI plates (Thermo Scientific,
NUNC, Madrid, Spain). Overnight cultures were diluted in
TSBg [TSB supplemented with 0.25% w/v D-(+)-glucose] up
to 106 CFU/ml and 200 μl were poured into each well and
incubated for 24 h at 37◦C. Wells were washed twice with sterile
phosphate-buffered saline (PBS buffer) (137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4 and 2 mM KH2PO4; pH 7.4). After
treatment of biofilms (see below), cultivable bacteria released
in the supernatant were counted by plating on TSA serial
dilutions. Moreover, cultivable adhered bacteria were determined
by scratching twice with a sterile swab and then immersed into
9 ml of PBS buffer followed by a vigorous shaking for 1 min.
Finally, several decimal dilutions were plated onto TSA and
incubated at 37◦C. Biomass quantification of biofilm adhered
to the surface of wells was carried out as previously described
(O’Neill et al., 2008). Briefly, wells were treated with crystal violet
(0.1% w/v) for 15 min, followed by a gentle wash with water
and de-staining in acetic acid (33% v/v). Finally, absorbance
was measured at 595 nm. To determine the matrix composition,
the biofilms were washed with PBS and then treated for 1 h
at 37◦C with a solution of 10 mM sodium metaperiodate
in 50 mM sodium acetate buffer (pH 4.5) (to disrupt the
extracellular polysaccharides), with 100 mg/ml of proteinase K
(Sigma, Madrid, Spain) in 20 mMTris HCl (pH 7.5) and 100 mM
NaCl, or with 100 mg/ml of DNaseI (Sigma, Madrid, Spain) in
150 mM of NaCl and 1 mM CaCl2 (Kaplan et al., 2004; Holland
et al., 2011). After treatments, the biofilms were washed with
water, stained with crystal violet, and the absorbance measured as
described above. All assays were performed using four biological
replicates.
Characterization of Dpo7 Activity
To determine the optimal conditions for Dpo7 activity, different
concentrations of the protein (0–1.5 μM) or PBS buffer for
control purposes, were added to 24 h-preformed biofilms of
S. epidermidis F12, and incubated for different times (30 min –
24 h) at temperatures ranging from 22 to 37◦C. Biofilm removal
was quantified by enumeration of cultivable bacteria and crystal
violet staining (see above).
FIGURE 1 | Purification of the recombinant exopolysaccharide
depolymerase Dpo7 from Escherichia coli BL21(DE3) pLys
pET21a-dpo7. L: Standard molecular weight marker in kDa (Low Range
Molecular Weight SDS-PAGE Standards, BioRad); Fraction eluted from nickel
affinity chromatography containing purified Dpo7. Bands indicated with a
black arrow were identified by mass spectrometry.
The activity of the protein was also tested against the biofilms
formed by other staphylococcal strains using 0.15 μM of Dpo7
for 3 h at 37◦C. All experiments were performed in triplicate.
The ability of Dpo7 to prevent biofilm formation was also
tested using a conventional broth microdilution technique. Two-
fold dilutions of Dpo7 (0–1.5 μM) in TSBg were added to TC
Microwell 96U w/lid nunclon D SI plates (Thermo Scientific,
NUNC, Madrid, Spain) in order to test biofilm formation and
to 96-Well MicrotiterTM Microplates (Thermo Scientific, NUNC,
Madrid, Spain) to assess planktonic bacterial growth. Each well
was inoculated with 106 CFU/well of bacteria. Plates were
incubated at 37◦C for 24 h. Biofilm formation was quantified by
crystal violet staining and measuring the absorbance at 595 nm.
Planktonic growth was determined by measuring the absorbance
at 600 nm of each supernatant.
Dpo7 activity against extracellular material was assessed by
using exponential cultures (OD600 = 0.6) of S. epidermidis F12
in TSBg. Cells were suspended in PBS buffer containing 0.15 μM
of Dpo7 and incubated for 3 h at 37◦C. Three microliter of the
cells diluted in 10 μl of 1% Congo red aqueous solution (Sigma–
Aldrich, St. Louis, MO, USA) were spread onto a glass slide
and air-dried. To visualize the extracellular material, staining
with Maneval’s solution was performed as previously described
(Cornelissen et al., 2011).
Quantification of lytic activity of Dpo7 was tested against live
S. epidermidis F12 cells prepared as previously described (Becker
et al., 2009), using the turbidity reduction assay (Obeso et al.,
2008).
The pH stability of the protein Dpo7 was tested by dilution
(1.5 μM) into the Britton–Robinson pH universal buffer
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FIGURE 2 | Activity of Dpo7 against 24 h-biofilms of Staphylococcus epidermidis F12 in PBS buffer at 37◦C. Biofilm disruption was determined using (A)
different concentrations of Dpo7 (μM) for 3 h at 37◦C and (B) 0.15 μM of Dpo7 throughout time ranging 30 min to 6 h. Total attached biomass was measured by
crystal violet staining after treatment and expressed as A595 units (); Adhered cultivable bacteria (●) and supernatant cultivable bacteria () are expressed as Log
(CFU/well). Each value corresponds to the mean ± standard deviation of three independent experiments.
(150 mM KCl, 10 mM KH2PO4, 10 mM sodium citrate, 10 mM
H3BO3, adjusted within a pH 3–11 range, and subsequent
maintenance at room temperature for 1 h. The protein was then
diluted 10-fold in PBS buffer. For control purposes, Britton–
Robinson buffer was diluted 10-fold in PBS buffer. Similarly, the
temperature stability was examined after incubation of 0.15 μM
of Dpo7 in PBS buffer for 30 min at different temperatures
(ranging from 40 to 90◦C). The activity of the protein after these
treatments was tested against 24 h-biofilms of S. epidermidis F12
as indicated above.
Statistical Analysis
A one-way analysis of variance (ANOVA) and the LSD test was
carried out to establish any significant differences regarding the
adhered cells and cells number in the supernatant and biomass
between the control and the treated biofilms. The differences
were expressed as the mean ± standard error and the level of
significance was established at P < 0.05 (SPSS11.0 Software for
windows; Chicago, IL, USA).
RESULTS
Dpo7 is Able to Remove S. epidermidis
Extracellular Material in Both Biofilms
and Planktonic Cells
To determine the activity of the recombinant protein Dpo7, a
synthetic gene with optimized codons was used for expression in
E. coli BL21 (DE3) pLysS as an N-terminal 6×-His-tagged fusion,
allowing purification by immobilized metal chelate affinity
chromatography. The purity of the protein was estimated to
be 95% as assessed by SDS-PAGE analysis (Figure 1). A main
band of about 98 kDa corresponding with the molecular weight
of Dpo7 was observed. A minor additional band (32 kDa) was
identified by mass-spectrometry as a degradation product of
Dpo7. Stocks of about 15 μM of protein were routinely obtained
in these conditions.
The activity of the recombinant Dpo7 was characterized by
treatment of 24 h-biofilms of the strain S. epidermidis F12 with
different concentrations of Dpo7 for 3 h at 37◦C (Figure 2A).
Total biomass that remained attached after the Dpo7 treatment
was quantified by crystal violet staining. The maximum biofilm
disruption (43%) was obtained with 0.075 μM and higher
concentrations (up to 1.5 μM) did not improve significantly this
result (P< 0.05). Moreover, the number of cultivable bacteria was
also determined after Dpo7 treatment. The maximum removal of
attached cells (about 1 log unit; 92% of the total) was obtained
treating the biofilms with 0.15 μM of the recombinant protein.
This value correlates with the increase in the number of cells in
the supernatant (Figure 2A) but the total cell number (adhered
plus planktonic) remained constant (data not shown), indicating
that biofilm-associated cells were released to the planktonic state
without any lytic activity of Dpo7. A turbidity reduction assay
confirmed the absence of lytic activity in Dpo7. There were
no statistical differences between the control and the treated
cells (data not shown). These results support the hypothesis
that the activity of Dpo7 is related with the degradation of
the extracellular material that surrounds the bacteria inside the
biofilm rather than lysis of the cells.
Once the Dpo7 minimum concentration to disrupt 50% of the
biofilm was established, an assay with different time exposures
was carried out at 37◦C (Figure 2B). For control purposes,
the number of cultivable bacteria and biomass staining were
recorded in biofilms treated only with PBS buffer for each time,
but no differences were observed during the assay. The results
showed that the protein was active and most of biofilm matrix
degradation took place within the first 30 min. The minimum
adhered cells and the maximum cells in the supernatants were
also detected 30 min after treatment, remaining stable until the
end of the exposure (Figure 2B). Longer times of incubation
(until 24 h) did not change these results.
The optimum parameters for Dpo7 activity were determined
by incubation at several temperatures (22, 32, and 37◦C). Dpo7
was active in all temperatures tested with increasing activity at
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FIGURE 3 | Temperature (A) and pH (B) stability of Dpo7. Temperature stability was tested by incubation of Dpo7 (0.15 μM) for 30 min and pH stability after
maintenance at room temperature for 1 h. C: control biofilm of S. epidermidis F12 without Dpo7 treatment; NT: activity of Dpo7 at pH 7.4 without temperature
treatment. Values represent the mean ± standard deviation of three independent experiments. Bars having an asterisk are statistically significant different from the
control and bars with a lower case ‘a’ indicate a statistically significant difference between the biofilm treatment with standard Dpo7 and the activity after thermal or
pH treatment (ANOVA; P < 0.05).
FIGURE 4 | Maneval’s staining of extracellular material in exponential-phase cultures of S. epidermidis F12 (A) before treatment and (B) after
treatment with 0.15 µM of Dpo7 for 3 h at 37◦C. A magnification of the figure allows for the comparison of the presence/absence of polysaccharide matrix
represented by a white halo surrounding the cell.
increasing temperature (25, 30, and 44% of biomass was removed
at 22, 32, and 37◦C, respectively). Dpo7 was found to be quite
thermostable as heat treatments up to temperatures of 70◦C did
not significantly affect the enzymatic activity (Figure 3A). Dpo7
was also stable in a range of pH from 6 to 8 (Figure 3B). After
90 days of storage a 4◦C, no decrease of activity was observed
(data not shown).
A qualitative approach about the potential of Dpo7 to degrade
the extracellular material formed by S. epidermidis F12 in
liquid cultures was obtained by staining and optical microscopy
(Figure 4). Cells grown to exponential phase were incubated
with 0.15 μM of Dpo7 for 3 h at 37◦C. Microscopic analysis
showed that non-treated cells are closely associated into small
clusters surrounded by a thin layer of negatively stained capsular
material (Figure 4A). After treatment with exopolysaccharide
(EPS) depolymerase Dpo7, the capsule is generally thinner or
drastically disrupted, and remaining capsular material devoid of
bacteria can be observed (Figure 4B).
The Exopolysaccharide is the Main
Substrate of Dpo7
To determine the specificity of Dpo7 for the components of
S. epidermidis biofilms, we tested its activity against biofilms with
different biochemical matrix compositions. Our S. epidermidis
and S. aureus strains collection was tested for matrix composition
by using treatment with either NaIO4, proteinase K and DNaseI,
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TABLE 2 | Estimation of the extracellular components in biofilms formed
by staphylococcal strains through the percentage of biofilm removing
after treatment.
Strain % of removed biofilm
NaIO4 Proteinase K DNase I
S. epidermidis F12 77.7 ± 9.0 1.9 ± 0.3 14 ± 5.9
B∗ 76.2 ± 8.2 2.7 ± 1.4 14.9 ± 3.1
DH3LIK 85 ± 3.8 5.9 ± 1.9 6.2 ± 1.2
YLIC13 71.8 ± 1.3 8 ± 1.8 22 ± 2.4
Z2LDC14 73.4 ± 2.8 7.7 ± 2.7 32.3 ± 5.5
DG2n∗ 75.2 ± 4.6 3.9 ± 1.5 24.7 ± 10.4
ASLD1 73.3 ± 5.6 0.5 ± 0.3 24.2 ± 7.1
LO5081 81.4 ± 9.6 9.7 ± 3.3 36.6 ± 3.3
LV5RB3 76.7 ± 4.2 8.1 ± 7.7 23.1 ± 6.4
LO5RB1 86.2 ± 6.0 6.1 ± 2.7 23.1 ± 9.5
S. aureus 15981∗ 88.7 ± 2.5 3.5 ± 0.9 1.6 ± 0.8
V329∗ 3.2 ± 5.1 88.7 ± 0.1 49.4 ± 2.2
∗Results published in Gutiérrez et al. (2014).
specific for exopolysaccharidic, proteinaceous and DNA matrix,
respectively. An estimation of the matrix composition was
made as function of the percentage of biofilm removal after
treatments. The results showed that all S. epidermidis strains
tested produced a matrix composed mainly of EPS as the highest
percentage of biofilm removal was obtained after treatment with
NaIO4. Strains S. aureus 15981 and S. aureus V329 formed
EPS and proteinaceous biofilms, respectively (Table 2). Dpo7
assays against 24 h-biofilms of S. epidermidis strains showed a
significant reduction in adhered cells from biofilms containing
an EPS matrix (Figure 5A). The decrease ranged from 1 log-unit
in the biofilm formed by S. epidermidis LO5RB1 to 2.3 log-
units in S. epidermidis DH3LIK biofilm. Moreover, an increase
in the number of cells was observed in the supernatant (data not
shown). As expected, the number of adhered cells in S. aureus
V329 biofilms was not reduced due to its proteinaceous biofilm
matrix but a clear reduction was observed in S. aureus 15981
(Figure 5A). These results were confirmed by staining the
total biomass with crystal violet. Dpo7 activity against EPS
biofilms showed a reduction of biomass ranging from 31%
in S. epidermidis ASLD1 to 75% in S. epidermidis LO5081,
remaining unaffected in S. aureus V329 (Figure 5B).
Dpo7 Prevents the Biofilm Formation on
Polystyrene Surfaces
In addition to the evaluation of Dpo7 to prevent biofilm
formation in staphylococcal strains, we tested the effect of the
protein on the planktonic growth of the strains. Microwell plates
filled with TSBg supplemented with Dpo7 (0–1.5 μM) were
inoculated with staphylococcal strains and the growth at 37◦C
was monitored by DO600 after 24 h of incubation. No statistically
significant differences were observed between planktonic cultures
treated and non-treated with Dpo7 at any assayed concentration.
Figure 6A shows results obtained at 0.15 μM Dpo 7 but higher
concentrations (up to 1.5 μM) did not affect planktonic growth.
In order to assess the ability of Dpo7 to prevent biofilm
formation, staphylococcal strains were also grown in the presence
of different concentrations (0–1.5 μM) of Dpo7 and checked
for biofilm formation by crystal violet staining. The presence of
0.15 μM of Dpo7 inhibited biofilm formation as total biomass
adhered to the polystyrene surface decreased from 27% in
S. epidermidis LV5RB3 to 85% in S. epidermidis Z2LDC14
FIGURE 5 | Removal of 24 h S. epidermidis and S. aureus biofilms after addition of Dpo7 (0.15 µM) for 3 h at 37◦C. (A) Adhered cultivable bacteria and (B)
crystal violet staining of control biofilms (black) and treated biofilms (white). Means and standard deviations were calculated from three biological replicates. Bars
having an asterisk are significantly different from the control (ANOVA; P < 0.05).
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FIGURE 6 | Biofilm growth inhibition in presence of Dpo7 (0.15 µM). (A) Planktonic growth of the cultures was determined by absorbance measurement at
600 nm after 24 h of incubation at 37◦C. (B) Percentage of biofilm inhibition was calculated by crystal violet staining of adhered cells after growth of 24 h biofilms.
Black bars represent the control values and white bars represent the values of wells treated with Dpo7. Means and standard deviations were calculated from three
biological replicates. Bars having an asterisk are significantly different from the control (ANOVA; P < 0.05).
(Figure 6B). Higher concentrations of Dpo7 (up to 1.5 μM)
did not improve these results (data not shown). However, the
presence of the Dpo7 did not affect biofilm formation in the
case of S. epidermidis B, DG2n, LO5RB1 and S. aureus V329
(Figure 6B).
DISCUSSION
In this study, we have purified a phage-derived EPS
depolymerase, Dpo7, which degrades the EPS matrix of
S. epidermidis and S. aureus biofilms. Apart from Dispersin B, an
N-acetylglucosaminidase enzyme produced by Aggregatibacter
actinomycetemcomitans (Izano et al., 2008), no other
enzymes degrading staphylococcal biofilm matrix formed
by polysaccharides have been described so far. This finding
prompted us to study Dpo7 as a strategy for controlling the
colonization and biofilm formation by staphylococcal pathogens.
The presence of depolymerases is common among phages,
playing a putative role in phage adsorption and infection
(Cornelissen et al., 2011, 2012). Similar proteins to Dpo7
are also present in three other Siphoviridae phages infecting
S. epidermidis (Daniel et al., 2007; Gutiérrez et al., 2012). All
phage EPS depolymerases characterized to date are enzymes that
hydrolyze polysaccharides or polysaccharide derivatives and are
common constituents of the tail spikes (Yan et al., 2014). For
instance, phage EPS depolymerases include endorhamnosidases
(Muller et al., 2008; Andres et al., 2010), alginate lyases
(Glonti et al., 2010), endosialidases (Jakobsson et al., 2007)
and hyaluronidases (Smith et al., 2005). Regarding Dpo7, it is
reasonable to hypothesize that it is associated to the capsid.
Indeed, Dpo7 amino acid sequence showed 99% homology
with a pre-neck appendage protein encoded by S. epidermidis
bacteriophage CNPH82 and high similarity in the tridimensional
structure with phi29 gp12 neck protein (Gutiérrez et al., 2012).
The protein Dpo7 contains a predicted pectin lyase domain,
the structure of which is composed of a right-handed β-helix
(Gutiérrez et al., 2012). Proteins containing these repeats
are usually enzymes with polysaccharide substrates, and this
topology is shared by several proteins, including bacterial pectate
lyases, fungal and bacterial galacturonases. Also, the phage
tail spike protein HylP1, encoded by l-like phage infecting
Streptococcus pyogenes, is a hyaluronidase with a similar structure
(Smith et al., 2005). Our results show that Dpo7 is involved in the
degradation of the EPS biofilm matrix of staphylococcal strains.
The ability of Dpo7 to disperse polysaccharide staphylococcal
preformed biofilms, but not the proteinaceous biofilm formed by
the strain S. aureus V329 supports this hypothesis. Degradation
of proteins associated with S. aureus biofilm formation and host–
pathogen interaction was previously described by S. epidermidis
protease Esp (Sugimoto et al., 2013).
In spite of the low identity (13%) and similarity (21%)
percentages between the amino acid sequences of Dpo7 and
DispersinB R© , the enzymatic activity and the optimum conditions
of Dpo7 were similar to those of DispersinB R© . Of note, the
last one has been proved to be effective removing over 85% of
the biomass of some staphylococcal biofilms when applying 40
or 50 μg ml−1 (Kaplan et al., 2003; Izano et al., 2008; Turk
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et al., 2013). The activity of Dpo7 was not dependent on the
ability of the strains to form weaker or stronger biofilms but
on the nature of the matrix. Indeed, the highest percentage of
biofilm removal was obtained against S. epidermidis Z2LDC14
and S. epidermidis LO5081, which showed a high and a moderate
ability to form biofilm, respectively, from among S. epidermidis
strains. We also observed that concentrations over 0.15 μM did
not improve biofilm dispersion even if time of treatment was
increased. The maintenance of the biofilm after the treatment
could be due to the heterogeneity of the biofilm matrix or to a
low diffusion of the protein within the biofilm. In EPS biofilms,
although the majority of the extracellular matrix is composed
of polysaccharides, interactions with eDNA and proteins should
not be discarded (Izano et al., 2008) therefore limiting the
potential of Dpo7 to remove the biofilm completely. This
limitation was also observed when using DispersinB R© to remove
biofilms formed by S. pseudintermedius (Turk et al., 2013). The
activity of this enzyme was dependent on the proportion of the
constituents of the biofilm matrix, which varies with the growth
conditions and among the different strains (Chaignon et al.,
2007). Moreover, PIA/PNAG molecules do not have a definite
structure and are not well-defined substrates, varying in length
and charge (Mack et al., 1996). It has been demonstrated that
the chain length of PIA/PNAG increased the catalytic efficiency
of DispersinB R© (Fazekas et al., 2012). Similarly, Dpo7 may
control EPS staphylococcal biofilms, but its activity could be
limited by the nature of the biofilm matrix, requiring the use
of combined treatments to completely eradicate the biofilm.
Combined treatments of DispersinB R© with antibacterials such
as triclosan or cefamandole nafate reduced colonization and
biofilm formation by S. aureus, S. epidermidis, and E. coli in
coated medical devices (Donelli et al., 2007; Darouiche et al.,
2009). Moreover, the development of an engineered enzymatic
bacteriophage (T7) modified to express DispersinB R© during
infection, enhanced the ability of the phage to reduce biofilms
formed by E. coli (Lu and Collins, 2007).
The relatively low activity of Dpo7 against extracellular
material allows us to speculate about the role of this protein in the
viral particle. Dpo7 might be implicated in the access of phage to
the bacterial surface without a total disaggregation of the biofilm
structure. Moreover, cells susceptible to phage attack should be
located in the outer zone of biofilms, where nutrients and oxygen
availability allow them to grow actively. Therefore, the biological
function of Dpo7 might not be the highly effective degradation of
extracellular EPS matrix but to open a local trajectory to enable
virion/cell contact.
Amajor finding of this study was that treatment of polystyrene
surfaces with Dpo7 inhibits the colonization by staphylococcal
strains. It seems that removal of the extracellular material at the
early stages of the culture is sufficient to prevent the adhesion of
most strains to the polystyrene surfaces. As deduced from our
results, Dpo7 is also able to remove extracellular material from
planktonic cells, resulting in the inhibition of biofilm formation.
This is in accordance with previous results obtained adding
DispersinB R© for biofilm prevention of several bacteria specific
strains such as S. epidermidis, E. coli, or Yersinia pestis, which
produce polysaccharidic matrixes (Itoh et al., 2005), and it was
also useful to reduce but not completely inhibit biofilm formation
of several strains of S. pseudintermedius (Turk et al., 2013).
All these results in addition to the lack of an antibacterial effect
of Dpo7 indicates that this enzyme would be used to remove
the extracellular material in staphylococcal strains to reduce their
virulence, since it has been shown that S. epidermidis mutants
deficient in the ability to synthesize PIA/PNAG are avirulent in
animal models of infection (Shiro et al., 1994). Similarly, biofilm
production by S. aureus is important for high-level virulence in
murine models of systemic infection, likely due to protection
of cells from host defenses (Kropec et al., 2005). Thus, Dpo7
may also be considered as an antivirulence compound. Generally,
resistance development against antivirulence compounds is
expected to be lower than against antibacterial compounds, as
the bacteria are only disarmed and not killed (Allen et al.,
2014). The efficacy of anti-biofilm enzymes has been proven
with DispersinB R© for the treatment of infectious diseases in
a chronic wound mouse model of MRSA infection (Gawande
et al., 2014), and in the reduction of colonization of catheters
by S. aureus (Darouiche et al., 2009). The removal of capsular
polysaccharide by the phage-encoded enzyme endosialidase E
reduces the virulence of E. coli K1 in a non-invasive model in
neonatal rats (Mushtaq et al., 2005). Similarly, depolymerase
enzymes encoded by phages infecting Erwinia amylovora have
been proposed in the control of plant diseases (Kim et al., 2004).
In addition, the removal of polymeric extracellular material
might improve the action of antibiotics against bacteria forming
biofilms, since physical interference could be avoided (Farber
et al., 1990; Alkawash et al., 2006).
This study supports that phages possess structural
components such as the novel EPS depolymerase (Dpo7)
that inhibit biofilm formation and disperses preformed biofilms
of S. epidermidis and S. aureus. These kinds of proteins might
constitute a new approach to remove biofilms, thus improving
the treatment of biofilm-associated recalcitrant infections.
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